BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33499584)

  • 1. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
    Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy.
    Xue T; Xu C; Wang Y; Wang Y; Tian H; Zhang Y
    Biomater Sci; 2019 Nov; 7(11):4615-4623. PubMed ID: 31441464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.
    Ling D; Li H; Xi W; Wang Z; Bednarkiewicz A; Dibaba ST; Shi L; Sun L
    J Mater Chem B; 2020 Feb; 8(6):1316-1325. PubMed ID: 31970370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-thin metal-organic framework nanosheets for chemo-photodynamic synergistic therapy.
    Zeng R; He T; Lu L; Li K; Luo Z; Cai K
    J Mater Chem B; 2021 May; 9(20):4143-4153. PubMed ID: 33973611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy.
    Xie R; Yang P; Peng S; Cao Y; Yao X; Guo S; Yang W
    J Mater Chem B; 2020 Jul; 8(28):6128-6138. PubMed ID: 32568335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale dual-enzyme cascade metal-organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy.
    Jin S; Weng L; Li Z; Yang Z; Zhu L; Shi J; Tang W; Ma W; Zong H; Jiang W
    J Mater Chem B; 2020 Jun; 8(21):4620-4626. PubMed ID: 32373876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-Organic Sheets for Efficient Drug Delivery and Bioimaging.
    Song Y; Yang J; Wang L; Xie Z
    ChemMedChem; 2020 Mar; 15(5):416-419. PubMed ID: 31919981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors.
    Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
    Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
    ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing-Linker-Assisted Artesunate Delivery by Metal-Organic Frameworks for Synergistic Cancer Treatment.
    Wang D; He IW; Liu J; Jana D; Wu Y; Zhang X; Qian C; Guo Y; Chen X; Bindra AK; Zhao Y
    Angew Chem Int Ed Engl; 2021 Dec; 60(50):26254-26259. PubMed ID: 34591365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.
    Zhang L; Yang X; Lv Y; Xin X; Qin C; Han X; Yang L; He W; Yin L
    Sci Rep; 2017 Apr; 7():46186. PubMed ID: 28383524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound and Near-Infrared Light Dual-Triggered Upconversion Zeolite-Based Nanocomposite for Hyperthermia-Enhanced Multimodal Melanoma Therapy via a Precise Apoptotic Mechanism.
    Zheng L; Zhang Y; Lin H; Kang S; Li Y; Sun D; Chen M; Wang Z; Jiao Z; Wang Y; Dai B; Zhuang S; Zhang D
    ACS Appl Mater Interfaces; 2020 Jul; 12(29):32420-32431. PubMed ID: 32573198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible Au@Ag nanorod@ZIF-8 core-shell nanoparticles for surface-enhanced Raman scattering imaging and drug delivery.
    Jiang P; Hu Y; Li G
    Talanta; 2019 Aug; 200():212-217. PubMed ID: 31036175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal organic framework coated MnO
    Nie Y; Li D; Peng Y; Wang S; Hu S; Liu M; Ding J; Zhou W
    Int J Pharm; 2020 Jul; 585():119513. PubMed ID: 32526334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose X-ray-Responsive Diselenide Nanocarriers for Effective Delivery of Anticancer Agents.
    Zhang L; Zhang S; Xu J; Li Y; He J; Yang Y; Huynh T; Ni P; Duan G; Yang Z; Zhou R
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43398-43407. PubMed ID: 33003260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.